Matches in Nanopublications for { ?s ?p "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP298676.RADY2OsSy91EWK75_EVqD8W_DlPWnR1rfTEPYJX5GAKKY130_assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298676.RADY2OsSy91EWK75_EVqD8W_DlPWnR1rfTEPYJX5GAKKY130_provenance.
- NP202302.RAku88GjhYV9KXQUSILu2grvN3OTSI_8iC6C0hhXdRBgc130_assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP202302.RAku88GjhYV9KXQUSILu2grvN3OTSI_8iC6C0hhXdRBgc130_provenance.
- NP830447.RAu4qeywUyi4IoSn3bBImT2ENB79dv7SIWf3v7BTwihLY130_assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830447.RAu4qeywUyi4IoSn3bBImT2ENB79dv7SIWf3v7BTwihLY130_provenance.
- NP833699.RArCrQL3kVviuQLmI3Ef8dR9ZtYZDmr3fPneXVz_jZvvg130_assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833699.RArCrQL3kVviuQLmI3Ef8dR9ZtYZDmr3fPneXVz_jZvvg130_provenance.
- assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP832960.RA0echIbKOvNDruQNn_dSHNsfeyKeDi-wJH_x-xhcO6xI130_assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832960.RA0echIbKOvNDruQNn_dSHNsfeyKeDi-wJH_x-xhcO6xI130_provenance.
- NP505172.RAID0y1oMtFPUbux5FdLiO6WytPR4_lkY1aCdXCNGbAGg130_assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505172.RAID0y1oMtFPUbux5FdLiO6WytPR4_lkY1aCdXCNGbAGg130_provenance.
- NP290580.RApp--hOwdL-Gmfg8yRBO9ZMjtREewRVic9F4myOVpQIo130_assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290580.RApp--hOwdL-Gmfg8yRBO9ZMjtREewRVic9F4myOVpQIo130_provenance.
- NP1066884.RA0H0gQuQw79oHDzEuvea5CrnCvtXMG2ERRlws2FMHW0Y130_assertion description "[Chimeric antigen receptor (CAR)-modified T cells targeting CD19 expressed by normal and malignant B cells is a unique therapy for patients with chronic lymphocytic leukemia (CLL); recent results highlight the potential of this therapy for patients with relapsed CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066884.RA0H0gQuQw79oHDzEuvea5CrnCvtXMG2ERRlws2FMHW0Y130_provenance.